213 related articles for article (PubMed ID: 9559806)
1. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Purimetla N; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Apr; 42(4):907-10. PubMed ID: 9559806
[TBL] [Abstract][Full Text] [Related]
2. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
[TBL] [Abstract][Full Text] [Related]
3. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Chauhan S; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2299-303. PubMed ID: 9736553
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.
Natarajan U; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1575-8. PubMed ID: 9210688
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
Kurita N; Brummer E; Oarada M; Miyaji M
Med Mycol; 2003 Apr; 41(2):131-6. PubMed ID: 12964845
[TBL] [Abstract][Full Text] [Related]
7. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
[TBL] [Abstract][Full Text] [Related]
8. Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Michelsen PB
J Antimicrob Chemother; 2008 Dec; 62(6):1285-90. PubMed ID: 18772160
[TBL] [Abstract][Full Text] [Related]
9. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
Sullivan GW; Carper HT; Mandell GL
Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells.
Yamamoto Y; Klein TW; Friedman H; Kimura S; Yamaguchi H
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):15-22. PubMed ID: 7689895
[TBL] [Abstract][Full Text] [Related]
11. Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
Brummer E; Kamei K; Miyaji M
Mycopathologia; 1998; 142(1):3-7. PubMed ID: 9850592
[TBL] [Abstract][Full Text] [Related]
12. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor.
Kletter Y; Bleiberg I; Golde DW; Fabian I
Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194
[TBL] [Abstract][Full Text] [Related]
13. Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole
Hassanpour P; Hamishehkar H; Bahari Baroughi B; Baradaran B; Sandoghchian Shotorbani S; Mohammadi M; Shomali N; Aghebati-Maleki L; Nami S
Assay Drug Dev Technol; 2021 Oct; 19(7):453-462. PubMed ID: 34435891
[No Abstract] [Full Text] [Related]
14. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
[TBL] [Abstract][Full Text] [Related]
15. The effects of fluconazole and cytokines on human mononuclear cells.
Fidan I; Yuksel S; Imir T; Kalkanci A; Kustimur S; Ilhan MN
Mem Inst Oswaldo Cruz; 2007 May; 102(2):127-31. PubMed ID: 17426874
[TBL] [Abstract][Full Text] [Related]
16. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils.
Richardson MD; Brownlie CE; Shankland GS
J Med Vet Mycol; 1992; 30(6):433-41. PubMed ID: 1287162
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
Rementeria A; Sanchez-Vargas LO; Villar M; Casals JB; Carrillo-Munoz AJ; Rodriguez Andres C; Eraso E; Quindos G
J Chemother; 2007 Apr; 19(2):172-7. PubMed ID: 17434826
[TBL] [Abstract][Full Text] [Related]
18. Priming of neutrophil and monocyte activation in human immunodeficiency virus infection. Comparison of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-gamma.
Meyer CN; Nielsen H
APMIS; 1996 Sep; 104(9):640-6. PubMed ID: 8972688
[TBL] [Abstract][Full Text] [Related]
19. The effect of GM-CSF and G-CSF on human neutrophil function.
Bober LA; Grace MJ; Pugliese-Sivo C; Rojas-Triana A; Waters T; Sullivan LM; Narula SK
Immunopharmacology; 1995 Mar; 29(2):111-9. PubMed ID: 7539779
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.
Tascini C; Vecchiarelli A; Preziosi R; Francisci D; Bistoni F; Baldelli F
AIDS; 1999 Jan; 13(1):49-55. PubMed ID: 10207544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
